Moderna ramps up manufacturing capacity to 1.4B doses for 2022

Cambridge biotech Moderna Inc. is ramping up the manufacturing capacity of its Covid-19 vaccine over the next two years. The plans call for 700 million doses in 2021, up from 600 million, and 1.4 billion doses in 2022. In a statement, Moderna (Nasdaq: MRNA) said it has already funneled additional investment into its manufacturing facilities and partner facilities, although spokesperson Ray Jordan declined to name specific locations or investment amounts. Moderna CEO Stephane Bancel has said that…
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Source Type: news